北京生物醫(yī)藥產(chǎn)業(yè)發(fā)展論壇（抉擇與突破）

報(bào)告論文
1·How will China Build Competitiveness in Capital and R&D
2·How to Develop Beijing as a Key Hub for Clinical Trials
3·Evolution of the Global Pharmaceutical Industry and Implications for Chinese MNC’s and domestic companies
4·Biotechnology Industry Development-Challenges and Opportunities
5·Drug Development, Registration and Marketing: the Role of the United States Pharmacopeia
6·Possible Ethnic Difference and Multinational Clinical Trial in China
7·我國(guó)創(chuàng)新藥研發(fā)現(xiàn)狀與對(duì)策
8·抓住機(jī)遇 發(fā)揮優(yōu)勢(shì) 做強(qiáng)做大北京醫(yī)藥產(chǎn)業(yè)
9·把握重大戰(zhàn)略機(jī)遇期 加快生物醫(yī)藥產(chǎn)業(yè)化
10·績(jī)業(yè)常青——打造21世紀(jì)的北京醫(yī)藥旗艦
11·以技術(shù)經(jīng)營(yíng)、產(chǎn)品經(jīng)營(yíng)、資本經(jīng)營(yíng)三項(xiàng)創(chuàng)新為源泉，提升科技型企業(yè)的市場(chǎng)競(jìng)爭(zhēng)
12·Advancing Healthcare Biotechnology without Borders
13·Recent Trend in Global Pharmaceutical Industry and Opportunities for China
14·Trends in Global Pharmaceutical R&D
15·R&D in this Decade：A Challenge for Pharma
16·藥物靶標(biāo)和心血管藥物研究進(jìn)展
17·Risk Management-application in Global Pharmaceutical Industry and Implication for China
18·ADME in silico預(yù)測(cè)在新藥研發(fā)中的應(yīng)用
19·發(fā)展戰(zhàn)略是中小企業(yè)的成長(zhǎng)前提和價(jià)值核心
20·淺談中藥藥代動(dòng)力學(xué)研究
21·生物技術(shù)藥物藥代動(dòng)力學(xué)
22·先導(dǎo)物藥代特性評(píng)價(jià)與新藥開(kāi)發(fā)
23·生物醫(yī)藥企業(yè)生存和發(fā)展
24·非專(zhuān)利藥的開(kāi)發(fā)和生產(chǎn)是我國(guó)制藥工業(yè)創(chuàng)新戰(zhàn)略的重要組成部分
25·治療阿爾茨海默病和其他認(rèn)知障礙的中藥研究
26·應(yīng)用獨(dú)家專(zhuān)利許可授權(quán)，加速中國(guó)專(zhuān)利創(chuàng)新藥的開(kāi)發(fā)
27·Technology Transfer, a Short-cut for Chinese Biopharmaeeutical Industry to Catch up North America and Europe
28·理想與現(xiàn)實(shí)——中小板醫(yī)藥公司價(jià)值定位初探
29·靶向給藥系統(tǒng)的研究進(jìn)展
30·醫(yī)藥領(lǐng)域許可證貿(mào)易經(jīng)營(yíng)方式探討一國(guó)際新藥開(kāi)發(fā)趨勢(shì)與德彪模式
31·Oral Delivery of Insulin
32·Challenges and Opportunities for Drug Development
33·Innovation Strategies in R & D
34·Developing an Antibody Drug—the Xolair Story and Biotech Opportunities in Asia
交流論文
1·毛冬青總皂苷緩釋微丸的制備及體外釋放度研究
2·真菌菌核的成分及活性研究進(jìn)展
3·生物醫(yī)藥專(zhuān)業(yè)孵化器現(xiàn)狀及運(yùn)營(yíng)模式分析探討
4·世界生物技術(shù)產(chǎn)業(yè)概況
5·我國(guó)基因工程制藥企業(yè)研發(fā)產(chǎn)出狀況統(tǒng)計(jì)分析
6·新藥研發(fā)過(guò)程中的項(xiàng)目管理
7·國(guó)家九五攻關(guān)課題-血脂康調(diào)整血脂對(duì)冠心病二級(jí)預(yù)防的研究（CCSPS）
8·一種新型高通量藥物篩選模式——使用動(dòng)物模型直接篩選神經(jīng)退行性疾病治療藥物
9·物理促滲技術(shù)和新型經(jīng)皮藥物組織浸潤(rùn)系統(tǒng)
10·專(zhuān)注一域 打造企業(yè)特色
11·凝血栓蛋白-1Ⅰ型重復(fù)序列對(duì)人血管內(nèi)皮細(xì)胞增殖影響的研究
12·利用科技資源推動(dòng)區(qū)域生物醫(yī)藥產(chǎn)業(yè)發(fā)展的幾點(diǎn)認(rèn)識(shí)